Accuro is improving patient care and administrative efficiency in low-resource settings. Anesthesiologist Dr. Audrey Alleyne discusses the tremendous benefits of the Accuro Neuraxial Guidance device for spinal and epidural anesthesia where time and access to ultrasounds are otherwise limited.
Recent Posts
- FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform
- RIVANNA Crosses 100-patent Threshold: Estate Protects Shared Platform Spanning Multiple FDA-cleared Product Lines
- RIVANNA Announces New CMS Procedure Code for Computer-aided Neuraxial Guidance
- The Inflection Point for Neuraxial Guidance
- Using AI to Strengthen Clinical Confidence: RIVANNA’s Will Mauldin on the Outcomes Rocket Podcast
